Queensenta®
Queensenta® is a complete analogue of Ozempic by Novo Nordisk, having the same composition and exactly the same effectiveness. Queensenta® is manufactured in Russia under strict control of Russian authorities , it's indicated for use in adult patients with type 2 diabetes mellitus during diet and exercise to improve glycemic control. Queensenta® reduces sugar to normal values, dulls the feeling of hunger and significantly reduces weight.
Queensenta® is manufactured in two options :
- 1 pre-filled pen of 3ml + 4 needles. The pen provides injections of 1ml.
- 1 pre-filled pen of 1.5ml + 6 needles. The pen provides injections of 0.5ml or 0.25ml.
Queensenta® is used once a week at any time, regardless of food intake. Queensenta® is injected subcutaneously into the abdomen, thigh or shoulder. The injection site can be changed without dose adjustment. Queensenta® cannot be administered intravenously or intramuscularly.
Queensenta®
in Cyrillic : Квинсента®
SUBSTANCE
Semaglutide
DOSAGE FORM
1.34 mg/ml pre-filled pen
MANUFACTURER
In Stock
available pack options :
| 1.5 ml pre-filled pen + 6 needles | $199.90 |
Related Products
